ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,059Medicare Part D Prescriptions Filled, Including Refills

Rank: 131 out of 337

$355K Total Retail Price of All Prescriptions

Rank: 128 out of 337

321 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 321 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 4,755 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
AMLODIPINE BESYLATE 640 547 1 3
OMEPRAZOLE 403 228 2 4
SIMVASTATIN 347 234 3 1
METFORMIN HCL 307 186 4 12
IBUPROFEN 273 122 5 64
METOPROLOL TARTRATE 190 173 6 6
HYDROCHLOROTHIAZIDE 188 134 7 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 188 119 7 31
ATORVASTATIN CALCIUM 166 145 9 7
GLIMEPIRIDE 157 108 10 55
LISINOPRIL 155 121 11 2
PRAVASTATIN SODIUM 150 88 12 14
RANITIDINE HCL 146 126 13 30
ATENOLOL 121 84 14 10
CRESTOR 113 53 15 29
FUROSEMIDE 106 97 16 8
LEVOTHYROXINE SODIUM 94 67 17 5
JANUVIA 92 55 18 81
FLUOXETINE HCL 90 42 19 57
SINGULAIR 83 55 20 113
PROAIR HFA 81 54 21 38
ZOLPIDEM TARTRATE 80 40 22 23
DIOVAN HCT 75 75 23 88
AMMONIUM LACTATE 75 54 23 250
LOSARTAN-HYDROCHLOROTHIAZIDE 74 59 25 60
ENALAPRIL MALEATE 73 49 26 37
AZITHROMYCIN 71 45 27 51
MONTELUKAST SODIUM 70 40 28 206
AMLODIPINE BESYLATE-BENAZEPRIL 67 32 29 97
LIPITOR 65 62 30 33
CITALOPRAM HBR 55 44 31 17
GLIPIZIDE 54 41 32 45
HYDROCODONE-ACETAMINOPHEN 53 22 S3 33 13
CLOBETASOL PROPIONATE 51 24 34 241
DIOVAN 50 39 35 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.